Further prognostic analysis of lnc NR2F1-AS1 suggested that high levels of lnc NR2F1-AS1 were associated with adverse overall survival (OS) and recurrence-free survival (RFS) of patients with BC, depending on Kaplan-Meier analysis (Fig. 1B). Here, NR2F1 is linked to breast cancer.